TECH vs TNXP · P/E 65, rev $1.22B vs rev $10.1M
Bio-Techne Corp (TECH) versus Tonix Pharmaceuticals Holding Corp (TNXP) — a side-by-side from cached financials, not a winner call.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Tonix Pharmaceuticals Holding Corp (TNXP) is a biotechnology company listed on NASDAQ.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Latest reported TNXP revenue for 2024-12-31 was $10.1M. Net income was -$130.0M. Revenue was up 29.9% from 2023-12-31 to 2024-12-31. TNXP currently screens at market cap $194.5M.
TECH currently screens at market cap $8.49B and trailing P/E 65.2. TNXP currently screens at market cap $194.5M.
Not investment advice. Open the TECH and TNXP stock pages for the full models.
Not investment advice.